SERRITELLI, EMMA NICOL
SERRITELLI, EMMA NICOL
Contribution of the Paraoxonase-2 Enzyme to Cancer Cell Metabolism and Phenotypes
2024-01-01 Campagna, R; Serritelli, En; Salvolini, E; Schiavoni, V; Cecati, M; Sartini, D; Pozzi, V; Emanuelli, M
Enhanced expression of nicotinamide N-methyltransferase in human osteosarcoma: potential role in tumor growth and chemoresistance
2023-01-01 Serritelli, En; Pozzi, V; Campagna, R; Sartini, D; Salvolini, E; Rubini, C; Goteri, G; Emanuelli, M
Involvment of the enzyme nicotinamide N-methyltransferase in proliferation, invasive capacity and chemosensitivity of human osteosarcoma.
2023-01-01 Serritelli, En; Pozzi, V; Campagna, R; Sartini, D; Salvolini, E; Rubini, C; Emanuelli, M
Knockdown of nicotinamide N-methyltransferase suppresses proliferation, migration and chemoresistance of Merkel cell carcinoma cells in vitro
2024-01-01 Pozzi, V; Molinelli, E; Campagna, R; Serritelli, En; Cecati, M; De Simoni, E; Sartini, D; Goteri, G; Martin, Ni; van Haren, Mj; Salvolini, E; Simonetti, O; Offidani, A; Emanuelli, M
Nicotinamide N-methyltransferase, a promising marker for human Merkel cell carcinoma
2023-01-01 Pozzi, V; Molinelli, E; Campagna, R; Serritelli, En; Cecati, M; Sartini, D; Goteri, G; Salvolini, E; Simonetti, O; Offidani, A; Emanuelli, M
Nicotinamide N-methyltransferase, a promising marker for human osteosarcoma
2022-01-01 Pozzi, V; Serritelli, En; Campagna, R; Sartini, D; Salvolini, E; Rubini, C; Emanuelli, M
Nicotinamide N-methyltransferase: a key enzyme of pyridine metabolism and a target for human osteosarcoma treatment
2023-01-01 Campagna, R; Serritelli, E. N.; Pozzi, V; Sartini, D; Salvolini, E; Rubini, C; Goteri, G; Emanuelli, M
Paraoxonase-2 is upregulated in triple negative breast cancer and contributes to tumor progression and chemoresistance
2023-01-01 Campagna, R; Pozzi, V; Giorgini, S; Morichetti, D; Goteri, G; Sartini, D; Serritelli, En; Emanuelli, M
Paraoxonase-2: a novel molecular target to enhance chemosensitivity in melanoma and triple negative breast cancer cells
2022-01-01 Campagna, R; Bacchetti, T; Salvolini, E; Pozzi, V; Serritelli, E; Giorgini, S; Molinelli, E; Simonetti, O; Sartini, D; Campanati, A; Ferretti, G; Goteri, G; Offidani, A; Emanuelli, M
Role of nicotinamide N-methyltransferase in human osteosarcoma: in vitro effect of shRNA-mediated gene silencing on tumorigenicity
2022-01-01 Serritelli, En; Pozzi, V; Campagna, R; Sartini, D; Salvolini, E; Rubini, C; Emanuelli, M.
Targeting nicotinamide N-methyltransferase decreased aggressiveness of osteosarcoma cells
2024-01-01 Serritelli, En; Sartini, D; Campagna, R; Pozzi, V; Martin, Ni; van Haren, Mj; Salvolini, E; Cecati, M; Rubini, C; Emanuelli, M
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Contribution of the Paraoxonase-2 Enzyme to Cancer Cell Metabolism and Phenotypes | 1-gen-2024 | Campagna, R; Serritelli, En; Salvolini, E; Schiavoni, V; Cecati, M; Sartini, D; Pozzi, V; Emanuelli, M | |
| Enhanced expression of nicotinamide N-methyltransferase in human osteosarcoma: potential role in tumor growth and chemoresistance | 1-gen-2023 | Serritelli, En; Pozzi, V; Campagna, R; Sartini, D; Salvolini, E; Rubini, C; Goteri, G; Emanuelli, M | |
| Involvment of the enzyme nicotinamide N-methyltransferase in proliferation, invasive capacity and chemosensitivity of human osteosarcoma. | 1-gen-2023 | Serritelli, En; Pozzi, V; Campagna, R; Sartini, D; Salvolini, E; Rubini, C; Emanuelli, M | |
| Knockdown of nicotinamide N-methyltransferase suppresses proliferation, migration and chemoresistance of Merkel cell carcinoma cells in vitro | 1-gen-2024 | Pozzi, V; Molinelli, E; Campagna, R; Serritelli, En; Cecati, M; De Simoni, E; Sartini, D; Goteri, G; Martin, Ni; van Haren, Mj; Salvolini, E; Simonetti, O; Offidani, A; Emanuelli, M | |
| Nicotinamide N-methyltransferase, a promising marker for human Merkel cell carcinoma | 1-gen-2023 | Pozzi, V; Molinelli, E; Campagna, R; Serritelli, En; Cecati, M; Sartini, D; Goteri, G; Salvolini, E; Simonetti, O; Offidani, A; Emanuelli, M | |
| Nicotinamide N-methyltransferase, a promising marker for human osteosarcoma | 1-gen-2022 | Pozzi, V; Serritelli, En; Campagna, R; Sartini, D; Salvolini, E; Rubini, C; Emanuelli, M | |
| Nicotinamide N-methyltransferase: a key enzyme of pyridine metabolism and a target for human osteosarcoma treatment | 1-gen-2023 | Campagna, R; Serritelli, E. N.; Pozzi, V; Sartini, D; Salvolini, E; Rubini, C; Goteri, G; Emanuelli, M | |
| Paraoxonase-2 is upregulated in triple negative breast cancer and contributes to tumor progression and chemoresistance | 1-gen-2023 | Campagna, R; Pozzi, V; Giorgini, S; Morichetti, D; Goteri, G; Sartini, D; Serritelli, En; Emanuelli, M | |
| Paraoxonase-2: a novel molecular target to enhance chemosensitivity in melanoma and triple negative breast cancer cells | 1-gen-2022 | Campagna, R; Bacchetti, T; Salvolini, E; Pozzi, V; Serritelli, E; Giorgini, S; Molinelli, E; Simonetti, O; Sartini, D; Campanati, A; Ferretti, G; Goteri, G; Offidani, A; Emanuelli, M | |
| Role of nicotinamide N-methyltransferase in human osteosarcoma: in vitro effect of shRNA-mediated gene silencing on tumorigenicity | 1-gen-2022 | Serritelli, En; Pozzi, V; Campagna, R; Sartini, D; Salvolini, E; Rubini, C; Emanuelli, M. | |
| Targeting nicotinamide N-methyltransferase decreased aggressiveness of osteosarcoma cells | 1-gen-2024 | Serritelli, En; Sartini, D; Campagna, R; Pozzi, V; Martin, Ni; van Haren, Mj; Salvolini, E; Cecati, M; Rubini, C; Emanuelli, M |